Skip to main content

Table 1 Participants’ characteristics at enrollment, Ankazomborona and Matanga Districts, Madagascar, 2018 (n = 344)

From: Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018

  Ankazomborona Matanga
ASAQ
(n = 86)
AL
(n = 86)
ASAQ
(n = 86)
AL
(n = 86)
Age (months), median (range) 100 (19–180) 108 (18–178) 72 (8–180) 60 (8–180)
Female, n (%) 37 (43) 34 (40) 41 (48) 42 (49)
Weight (kg), mean, sd 21 (8) 21 (8) 18 (7) 18 (8)
Baseline parasitemia, median parasites/µL (range) 22,293 (1007–88,492) 22,249 (1162–93,915) 11,507 (1093–91,264) 17,445 (1036–94,717)
Gametocytemia on day 0, n (%) 3 (3) 3 (3) 4 (5) 2 (2)
Reached Study end point, n (%) 83 (97) 85 (99) 84 (98) 83 (97)
  1. ASAQ artesunate-amodiaquine, AL artemether-lumefantrine, sd standard deviation